logo-loader

Salt Lake Potash non-executive director Bryn Jones thanked for contribution

Published: 01:35 04 May 2021 EDT

Salt Lake Potash Ltd -
Construction work on the final components of on-lake infrastructure will begin this quarter at Lake Way

Salt Lake Potash Ltd (ASX:SO4) (LON:SO4) (OTCMKTS:WHELF) (FRA:W1D) has unveiled a change in its board with the resignation of Bryn Jones as a non-executive director.

Bryn, who was appointed to the board in June 2017 is stepping down due to increased work commitments outside of SO4.

Thanked for contribution

Chief executive officer Tony Swiericzuk said: “I would like to thank Bryn for his contribution to SO4, in particular his technical input during the company’s formative years.

“We wish him well as he focuses on his other business interests.”

Confidence in Lake Way Project

Jones said: “I have thoroughly enjoyed my time at SO4 and am confident that the board, management team and importantly, the Lake Way Project will form the basis of a strong company moving forward in an exciting new industry for Western Australia.”

Final environmental approval

The company recently received its Part IV Environmental Approval for the Lake Way Project in Western Australia covering full-scale operations of 245,000 tonnes per annum of sulphate of potash (SOP).

This permit enables SO4 to finalise the construction of pond trains 4-6 as well as associated trench and bore construction that will support full-scale operations at Lake Way.

Construction of the final components of the on-lake infrastructure will begin this quarter.

The Part IV Environmental submission has been approved by the WA Government, having been recommended by the EPA with no appeals in January 2021.

BenevolentAI advances novel ulcerative colitis treatment through Phase 1a trial

BenevolentAI (OTC:BAIVF) chief scientific officer Dr Anne Phelan joins Proactive's Stephen Gunnion with positive safety data from the Phase 1a, first-in-human, clinical study of BEN-8744 in healthy volunteers. Phelan explained that BEN-8744 is a potent, selective PD10 inhibitor, uniquely...

1 hour, 45 minutes ago